John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OB
1401
DELISTED
Onebeacon Insurance Group Ltd
OB
| $1.34M | 0.01% |
88,031
+47,855
| +119% | +$747K |
|
1402
PUT
Oracle
ORCL
$410B
| $1.34M | 0.01% |
+31,000
| New | +$1.34M |
|
|
ATCO
1403
DELISTED
Atlas Corp.
ATCO
| $1.34M | 0.01% |
73,294
-5,354
| -7% | -$98K |
|
1404
Bank of America
BAC
$436B
| $1.33M | 0.01% |
+86,600
| New | +$1.39M |
|
1405
CF Industries
CF
$19.6B
| $1.33M | 0.01% |
23,500
+5,075
| +28% | +$302K |
|
|
SYNT
1406
DELISTED
Syntel Inc
SYNT
| $1.33M | 0.01% |
25,745
+1,922
| +8% | +$91.4K |
|
|
HPTX
1407
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.33M | 0.01% |
28,907
-50,049
| -63% | -$1.5M |
|
|
SRDX
1408
DELISTED
Surmodics
SRDX
| $1.32M | 0.01% |
50,700
-6,529
| -11% | -$156K |
|
1409
PUT
LyondellBasell Industries
LYB
$21.1B
| $1.32M | 0.01% |
+15,000
| New | +$1.26M |
|
1410
KRONOS Worldwide
KRO
$1B
| $1.32M | 0.01% |
103,994
+50,029
| +93% | +$608K |
|
1411
CALL
Fluor
FLR
$6.86B
| $1.31M | 0.01% |
+23,000
| New | +$1.31M |
|
|
HVB
1412
DELISTED
HUDSON VY HLDG CORP
HVB
| $1.31M | 0.01% |
51,433
-23,594
| -31% | -$606K |
|
1413
Stellantis
STLA
$19.7B
| $1.31M | 0.01% |
123,464
-803,911
| -87% | -$7.52M |
|
1414
STAG Industrial
STAG
$7.14B
| $1.31M | 0.01% |
55,722
-1,161
| -2% | -$29.2K |
|
|
CLGX
1415
DELISTED
Corelogic, Inc.
CLGX
| $1.31M | 0.01% |
37,154
-269,387
| -88% | -$9.1M |
|
|
AL
1416
DELISTED
Air Lease Corp
AL
| $1.31M | 0.01% |
+34,618
| New | +$1.27M |
|
1417
WPP
WPP
$5.83B
| $1.31M | 0.01% |
11,482
+2,546
| +28% | +$286K |
|
1418
Highwoods Properties
HIW
$3.5B
| $1.3M | 0.01% |
+28,460
| New | +$1.31M |
|
1419
Acco Brands
ACCO
$387M
| $1.3M | 0.01% |
156,692
-655,369
| -81% | -$5.2M |
|
1420
Amphastar Pharmaceuticals
AMPH
$915M
| $1.3M | 0.01% |
87,057
+47,398
| +120% | +$634K |
|
1421
PUT
Altria Group
MO
$114B
| $1.3M | 0.01% |
+26,000
| New | +$1.38M |
|
|
CSG
1422
DELISTED
CHAMBERS STR PPTYS COM
CSG
| $1.3M | 0.01% |
165,154
-362,516
| -69% | -$2.98M |
|
|
CRRC
1423
DELISTED
COURIER CORP
CRRC
| $1.3M | 0.01% |
53,114
+26,067
| +96% | +$571K |
|
1424
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
| $1.3M | 0.01% |
+12,100
| New | +$1.29M |
|
1425
Innospec
IOSP
$2.33B
| $1.29M | 0.01% |
27,845
-8,560
| -24% | -$367K |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.